Repeated intratracheal instillations of nonreplicating adenovirus 2 vector attenuate CTL responses and IFN-γ production

Journal of Immunology

Volumn 160, Issue 9, 1998, Pages 4465-4472

  Pascual, David W ^a   Walters, Nancy ^a   Hillemeyer, Peter ^a  

^a MONTANA STATE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CD4 ANTIGEN; CD8 ANTIGEN; CYTOKINE; GAMMA INTERFERON; IMMUNOGLOBULIN A; IMMUNOGLOBULIN G; INTERLEUKIN 10; INTERLEUKIN 4; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 1; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 2; MESSENGER RNA; PROTEIN;

ADENOVIRUS; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CYTOTOXIC T LYMPHOCYTE; ENZYME LINKED IMMUNOSORBENT ASSAY; GENE EXPRESSION; GENE THERAPY; IMMUNIZATION; LYMPH NODE; LYMPHOID CELL; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; RESPIRATORY EPITHELIUM; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SPLEEN;

ADENOVIRIDAE; ADMINISTRATION, INHALATION; ANIMALS; CYTOTOXICITY, IMMUNOLOGIC; GENE THERAPY; GENETIC VECTORS; IMMUNITY, MUCOSAL; INTERFERON TYPE II; MALE; MICE; MICE, INBRED C57BL; T-LYMPHOCYTES, CYTOTOXIC; VACCINATION;

EID: 0032080607     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (39)

1. Simon, R. H., J. F. Engelhardt, Y. Yang, M. Zepeda, S. Weber-Pendleton, M. Grossman, and J. M. Wilson. 1993. Adenovinis-mediated transfer of the CFTR gene to lung of nonhuman primates: toxicity study. Hum. Gene Ther. 4:771.
2. Yei, S., N. Mittereder, S. Wert, J. A. Whitsett, R. W. Wilmott, and B. C. Trapnell. 1994. In vivo evaluation of the safety of adenovirus-mediated transfer of the human cystic fibrosis transmembrane conductance regulator cDNA to the lung. Hum. Gene Ther. 5:731.
3. Zabner, J., D. M. Petersen, A. P. Puga, S. M. Graham, L. A. Couture, L. D. Keyes, M. J. Lukason, A. St. George, R. J. Gregory, and A. E. Smith. 1994. Safety and efficacy of repetitive adenovirus-mediated transfer of CFTR cDNA to airway epithelia of primates and cotton rats. Nat. Genet. 6:75.
4. Yang, Y., H. C. Ertl, and J. M. Wilson. 1994. MHC class I-restricted cytotoxic T lymphocytes to viral antigens destroy hepatocytes in mice infected with E1-deleted recombinant adenoviruses. Immunity 1:433.
5. Yang, Y., Q. Li, H. C. Ertl, and J. M. Wilson. 1995. Cellular and humoral immune responses to viral antigens create barriers to lung-directed gene therapy with recombinant adenoviruses. J. Virol. 69:2004.
6. van Ginkel, F. W., C.-G. Liu, J. W. Simecka, J.-Y. Dong, T. Greenway, R. A. Frizzell, H. Kiyono, J. R. McGhee, and D. W. Pascual. 1995. Intratracheal gene delivery with adenoviral vector induces elevated systemic IgG and mucosal IgA antibodies to adenovirus and β-galactosidase. Hum. Gene Ther. 6:895.
7. van Ginkel, F. W., J. R. McGhee, C. G. Liu, J. W. Simecka, M. Yamamoto, R. A. Frizzell, E. J. Sorscher, H. Kiyono, and D. W. Pascual. 1997. Adenoviral gene delivery elicits distinct pulmonary-associated T helper cell responses to the vector and to its transgene. J. Immunol. 159:685.
8. Kaplan, J. M., D. Armentano, T. E. Sparer, S. G. Wynn, P. A. Peterson, S. C. Wadsworth, K. K. Couture, S. E. Pennington, J. A. St. George, L. R. Gooding, and A. E. Smith. 1997. Characterization of factors involved in modulating persistence of transgene expression from recombinant adenovirus in the mouse lung. Hum. Gene Ther. 8:45.
9. Yang, Y., Q. Su, and J. M. Wilson. 1996. Role of viral antigens in destructive cellular immune responses to adenovirus vector-transduced cells in mouse lungs. J. Virol. 70:7209.
10. Barr, D., J. Tubb, D. Ferguson, A. Scaria, A. Lieber, C. Wilson, J. Perkins, and M. A. Kay. 1995. Strain related variations in adenovirally mediated transgene expression from mouse hepatocytes in vivo: comparisons between immunocompetent and immunodeficient inbred strains. Gene Ther. 2:151.
11. Yang, Y., Z. Xiang, E. C. Ertl, and J. M. Wilson. 1995. Up regulation of class I major histocompatibility complex antigens by interferon γ is necessary for T-cellmediated elimination of recombinant adenovirus-infected hepatocytes in vivo. Proc. Natl. Acad. Sci. USA 92:7257.
12. Yang, Y., G. Trinchieri, and J. M. Wilson. 1995. Recombinant IL-12 prevents formation of blocking IgA antibodies to recombinant adenovirus and allows repeated gene therapy to mouse lung. Nat. Med. 1:890.
13. Yang, Y., F. A. Nunes, K. Berensci, E. E. Furth, E. Gonczol, and J. M. Wilson. 1994. Cellular immunity to viral antigens limits E1-deleted adenoviruses for gene therapy. Proc. Natl. Acad. Sci. USA 91:4407.
14. Ada, G. L., and R. V. Blanden. 1994. CTL immunity and cytokine regulation in viral infection. Res. Immunol. 145:625.
15. Riddell, S. R., and P. D. Greenberg. 1995. Principles of adoptive T cell therapy of human viral diseases. Annu. Rev. Immunol. 13:545.
16. Rawle, F. C., B. B. Knowles, R. P. Ricciardi, V. Brahmacheri, P. Duerksen-Hughes, W. S. M. Wold, and L. R. Gooding. 1991. Specificity of the mouse cytotoxic T lymphocyte response to adenovirus 5. J. Immunol. 146:3977.
17. Mullbacher, A., A. J. D. Bellett, and R. T. Hla. 1989. The murine cellular immune response to adenovirus type 5. Immunol. Cell Biol. 67:31.
18. Lichtenfels, R., W. E. Biddison, H. Schulz, A. B. Vogt, and R. Martin. 1994. CARE-LASS (calcein-release-assay). an improved fluorescence-based test system to measure cytotoxic T lymphocyte activity. J. Immunol. Methods 172:227.
19. Van Cott, J. L., H. F. Staats, D. W. Pascual, M. Roberts, S. N. Chatfield, M. Yamamoto, P. B. Carter, H. Kiyono, and J. R. McGhee. 1996. Regulation of mucosal and systemic antibody responses by T helper cell subsets, macrophages, and derived cytokines following oral immunization with live recombinant Salmonella. J. Immunol. 156:1504.
20. Zsengeller, Z.-K., S. E. Wert, W. M. Hull, X. Hu, S. Yei, B. C. Trapnell, and J. A. Whitsett. 1995. Persistence of replication-deficient adenovirus-mediated gene transfer in lungs of immune-deficient (nu/nu) mice. Hum. Gene Ther. 6:457.
21. Holt, P. G., A. Degebrodt, C. O'Leary, K. Krska, and T. Plozza. 1985. T cell activation by antigen-presenting cells from lung tissue digests: suppression by endogenous macrophages. Clin. Exp. Immunol. 62:586.
22. Strickland, D. H., U. R. Kees, and P. G. Holt. 1994. Suppression of T-cell activation by pulmonary alveolar macrophages: dissociation of effects on TcR, IL-2R expression, and proliferation. Eur. Respir. J. 7:2124.
23. Jassoy, C., T. Harrer, T. Rosenthal, B. A. Navia, J. Worth, R. P. Johnson, and B. D. Walker. 1993. Human immunodeficiency virus type 1-specific cytotoxic T lymphocytes release γ interferon, tumor necrosis factor a (TNF-α), and TNF-β when they encounter their target antigens. J. Virol. 67:2844.
24. + T cells. Int. Immunol. 6:11.
25. Rosenfeld, M. A., K. Yoshimura, B. C. Trapnell, K. Yoneyama, E. R. Rosenthal, W. Dalemans, M. Fukayama, J. Bargon, L. E. Stier, L. Stratford-Perricaudet, M. Perricaudet, B. W. Guggino, A. Pavirani, J.-P. Lecocq, and R. G. Crystal. 1992. In vivo transfer of the human cystic fibrosis transmembrane conductance regulator gene to the airway epithelium. Cell 68:143.
26. Zabner, J., L. A. Couture, R. J. Gregory, S. M. Graham, A. E. Smith, and M. J. Welsh. 1993. Adenovirus-mediated gene transfer transiently corrects the chloride transport defect in nasal epithelia of patients with cystic fibrosis. Cell 75:1.
27. Graham, F. L., and L. Prevec. 1992. Adenovirus-based expression vectors and recombinant vaccines. In: Vaccines: New Approaches to Immunological Problems. R. W. Ellis, ed. Butterworth-Heinemann, Boston, pp. 363.
28. Ayers, M. M., and P. K. Jeffery. 1988. Proliferation and differentiation in mammalian airway epithelium. Eur. Respir. J. 1:58.
29. Thaete, L. G., D. J. Ahnen, and A. M. Malkinson. 1989. Proliferating cell nuclear antigen (PCNA/cyclin) immunocytochemistry as a labeling index in mouse lung tissues. Cell Tissue Res. 256:167.
30. Dong, J.-Y., D. Wang, F. W. van Ginkel, D. W. Pascual, and R. A. Frizzell. 1996. Systematic analysis of repeated gene delivery into animal lungs with recombinant adenovirus vector. Hum. Gene Ther. 7:319.
31. Tripathy, S. K., H. B. Black, E. Goldwasser, and J. M. Leiden. 1996. Immune responses to transgene-encoded proteins limit the stability of gene expression after injection of replication-defective adenovirus vectors. Nat. Med. 2:545.
32. Morral, N., W. O'Neal. H. Zhou, C. Langston, and A. Beaudet. 1997. Immune responses to reporter proteins and high viral dose limit duration of expression with adenoviral vectors: comparison of E2a wild type and E2a deleted vectors. Hum. Gene Ther. 8:1275.
33. Song, W., H.-L. Kong, P. Traktman, and R. G. Crystal. 1997. Cytotoxic T lymphocyte responses to proteins encoded by heterologous transgenes transferred in vivo by adenoviral vectors. Hum. Gene Ther. 8:1207.
34. Burgert, H., and Kvist, S. 1985. An adenovirus type 2 glycoprotein blocks cell surface expression of human histocompatibility class I antigens. Cell 41:987.
35. Hermiston, T. W., R. A. Tripp, T. Sparer, L. R. Gooding, and W. S. Wold. 1993. Deletion mutation analysis of the adenovirus type 2 E3-gp19K protein: identification of sequences within the endoplasmic reticulum lumenal domain that are required for class I antigen binding and protection from adenovirus-specific cytotoxic T lymphocytes. J. Virol. 67:5289.
36. Fiorentino, D. F., M. A. Bond, and T. R. Mosmann. 1989. Two types of mouse T helper T cells. IV. Th2 clones secrete a factor that inhibits cytokine production. J. Exp. Med. 170:2081.
37. Romani, L., P. Puccetti, A. Mencacci, E. Cenci, R. Spaccapelo, L. Tonnetti, U. Grohmann, and F. Bistoni. 1994. Neutralization of IL-10 up-regulates nitric oxide production and protects susceptible mice from challenge with Candida albicans. J. Immunol 152:3514.
38. van Ginkel, F. W., C. Liu, Y. Yang, J. M. Wilson, E. J. Sorscher, D. W. Pascual, R. A. Frizzel, H. Kiyono, and J. R. McGhee. 1996. Influence of adenovirus early gene deletions on mucosal immunity to vector and transgene. Ped. Pulmon. 13(Suppl.):272 (Abstr. 227).
39. Mack, C. A., W. R. Song, H. Carpenter, T. J. Wickham, I. Kovesdi, B. G. Harvey, C. J. Magovern, O. W. Isom, T. Rosengart, E. Falck-Pedersen, N. R. Hackett, R. G. Crystal, and A. Mastrangeli. 1997. Circumvention of anti-adenovirus neutralizing immunity by administration of an adenoviral vector of an alternate serotype. Hum. Gene Ther. 8:99.